CalciMedica is trading 13.91% up at $1.31 on October 23, 2026; no clear company-specific catalyst has been identified. - Coverage also described the October 22 after-hours rise as lacking a clear catalyst. - The recent CFO resignation and $25 million at-the-market stock program were reported before October 23, but available sources do not establish either as the cause of the gain. - Broader markets were mixed-to-lower, and available evidence does not clearly explain the move as market-driven.